Cochrane Abstracts
Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Laryngeal Mask Airway Surfactant Administration for Prevention of Morbidity and Mortality in Preterm Infants With or at Risk of Respiratory Distress Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431966/all/Laryngeal_mask_airway_surfactant_administration_for_prevention_of_morbidity_and_mortality_in_preterm_infants_with_or_at_risk_of_respiratory_distress_syndrome.
Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431966/all/Laryngeal_mask_airway_surfactant_administration_for_prevention_of_morbidity_and_mortality_in_preterm_infants_with_or_at_risk_of_respiratory_distress_syndrome. Accessed December 7, 2024.
Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431966/all/Laryngeal_mask_airway_surfactant_administration_for_prevention_of_morbidity_and_mortality_in_preterm_infants_with_or_at_risk_of_respiratory_distress_syndrome
Laryngeal Mask Airway Surfactant Administration for Prevention of Morbidity and Mortality in Preterm Infants With or at Risk of Respiratory Distress Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431966/all/Laryngeal_mask_airway_surfactant_administration_for_prevention_of_morbidity_and_mortality_in_preterm_infants_with_or_at_risk_of_respiratory_distress_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome
ID - 431966
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431966/all/Laryngeal_mask_airway_surfactant_administration_for_prevention_of_morbidity_and_mortality_in_preterm_infants_with_or_at_risk_of_respiratory_distress_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
